ImmuPharma Income Before Tax vs Interest Income Analysis

IMM Stock   3.55  0.28  7.31%   
ImmuPharma PLC financial indicator trend analysis is infinitely more than just investigating ImmuPharma PLC recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether ImmuPharma PLC is a good investment. Please check the relationship between ImmuPharma PLC Income Before Tax and its Interest Income accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmuPharma PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Income Before Tax vs Interest Income

Income Before Tax vs Interest Income Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of ImmuPharma PLC Income Before Tax account and Interest Income. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between ImmuPharma PLC's Income Before Tax and Interest Income is -0.27. Overlapping area represents the amount of variation of Income Before Tax that can explain the historical movement of Interest Income in the same time period over historical financial statements of ImmuPharma PLC, assuming nothing else is changed. The correlation between historical values of ImmuPharma PLC's Income Before Tax and Interest Income is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Income Before Tax of ImmuPharma PLC are associated (or correlated) with its Interest Income. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Income has no effect on the direction of Income Before Tax i.e., ImmuPharma PLC's Income Before Tax and Interest Income go up and down completely randomly.

Correlation Coefficient

-0.27
Relationship DirectionNegative 
Relationship StrengthInsignificant

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on ImmuPharma PLC income statement and is an important metric when analyzing ImmuPharma PLC profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.
Most indicators from ImmuPharma PLC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ImmuPharma PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmuPharma PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
The current year's Selling General Administrative is expected to grow to about 1.7 M, whereas Tax Provision is forecasted to decline to (600.3 K).
 2022 2023 2024 2025 (projected)
Interest Expense1.5M2.0K2.3K2.2K
Depreciation And Amortization117.6K37.6K43.2K84.5K

ImmuPharma PLC fundamental ratios Correlations

-0.38-0.10.99-0.930.390.930.15-0.460.630.93-0.25-0.410.12-0.270.270.97-0.320.670.16-0.350.23-0.10.440.25-0.24
-0.380.66-0.450.33-0.55-0.34-0.08-0.17-0.38-0.340.630.81-0.090.540.5-0.380.68-0.37-0.230.41-0.07-0.06-0.5-0.460.55
-0.10.66-0.210.21-0.69-0.210.210.15-0.03-0.210.770.770.130.650.77-0.190.78-0.270.320.740.060.43-0.33-0.750.75
0.99-0.45-0.21-0.920.420.910.19-0.440.590.91-0.3-0.470.12-0.290.140.95-0.370.640.15-0.410.21-0.130.470.29-0.28
-0.930.330.21-0.92-0.57-1.00.070.63-0.49-1.00.430.490.170.46-0.27-0.960.46-0.780.070.46-0.110.26-0.44-0.490.4
0.39-0.55-0.690.42-0.570.6-0.59-0.420.370.6-0.95-0.9-0.17-0.95-0.160.57-0.950.76-0.35-0.730.22-0.560.480.83-0.77
0.93-0.34-0.210.91-1.00.6-0.11-0.610.521.0-0.45-0.52-0.17-0.50.290.97-0.490.82-0.07-0.490.12-0.270.480.5-0.41
0.15-0.080.210.190.07-0.59-0.110.41-0.15-0.110.560.330.040.62-0.21-0.10.49-0.390.480.25-0.340.40.1-0.460.44
-0.46-0.170.15-0.440.63-0.42-0.610.41-0.07-0.610.30.20.140.39-0.21-0.580.27-0.370.360.2-0.120.250.09-0.50.34
0.63-0.38-0.030.59-0.490.370.52-0.15-0.070.52-0.32-0.430.41-0.220.30.63-0.380.480.25-0.20.51-0.10.17-0.09-0.19
0.93-0.34-0.210.91-1.00.61.0-0.11-0.610.52-0.45-0.52-0.17-0.50.290.97-0.490.82-0.07-0.490.12-0.270.480.5-0.41
-0.250.630.77-0.30.43-0.95-0.450.560.3-0.32-0.450.940.190.940.34-0.420.99-0.610.370.69-0.140.5-0.39-0.820.84
-0.410.810.77-0.470.49-0.9-0.520.330.2-0.43-0.520.940.070.880.39-0.520.97-0.630.140.68-0.160.37-0.53-0.740.78
0.12-0.090.130.120.17-0.17-0.170.040.140.41-0.170.190.070.230.020.080.14-0.190.30.20.750.14-0.21-0.420.18
-0.270.540.65-0.290.46-0.95-0.50.620.39-0.22-0.50.940.880.230.17-0.450.93-0.730.320.65-0.110.41-0.47-0.880.75
0.270.50.770.14-0.27-0.160.29-0.21-0.210.30.290.340.390.020.170.290.360.330.080.350.230.13-0.12-0.310.35
0.97-0.38-0.190.95-0.960.570.97-0.1-0.580.630.97-0.42-0.520.08-0.450.29-0.470.790.01-0.440.3-0.220.430.41-0.38
-0.320.680.78-0.370.46-0.95-0.490.490.27-0.38-0.490.990.970.140.930.36-0.47-0.630.310.71-0.160.5-0.45-0.790.83
0.67-0.37-0.270.64-0.780.760.82-0.39-0.370.480.82-0.61-0.63-0.19-0.730.330.79-0.63-0.12-0.650.11-0.370.660.61-0.45
0.16-0.230.320.150.07-0.35-0.070.480.360.25-0.070.370.140.30.320.080.010.31-0.120.33-0.070.740.23-0.430.64
-0.350.410.74-0.410.46-0.73-0.490.250.2-0.2-0.490.690.680.20.650.35-0.440.71-0.650.330.080.71-0.64-0.660.55
0.23-0.070.060.21-0.110.220.12-0.34-0.120.510.12-0.14-0.160.75-0.110.230.3-0.160.11-0.070.08-0.22-0.14-0.13-0.13
-0.1-0.060.43-0.130.26-0.56-0.270.40.25-0.1-0.270.50.370.140.410.13-0.220.5-0.370.740.71-0.22-0.25-0.380.51
0.44-0.5-0.330.47-0.440.480.480.10.090.170.48-0.39-0.53-0.21-0.47-0.120.43-0.450.660.23-0.64-0.14-0.250.4-0.13
0.25-0.46-0.750.29-0.490.830.5-0.46-0.5-0.090.5-0.82-0.74-0.42-0.88-0.310.41-0.790.61-0.43-0.66-0.13-0.380.4-0.76
-0.240.550.75-0.280.4-0.77-0.410.440.34-0.19-0.410.840.780.180.750.35-0.380.83-0.450.640.55-0.130.51-0.13-0.76
Click cells to compare fundamentals

ImmuPharma PLC Account Relationship Matchups

ImmuPharma PLC fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets10.9M6.0M4.0M2.7M2.4M2.3M
Other Current Liab110.7K158.8K200.0K768.5K691.7K726.3K
Total Current Liabilities1.3M1.6M1.5M1.7M1.9M1.4M
Total Stockholder Equity9.7M4.4M2.5M1.1M950.7K903.1K
Net Debt(5.2M)(1.6M)(667.7K)(208.5K)(239.8K)(251.7K)
Retained Earnings(46.0M)(56.6M)(61.1M)(64.1M)(57.7M)(54.8M)
Cash5.9M1.6M667.8K208.5K187.6K178.3K
Non Current Assets Total3.5M2.7M1.6M1.4M1.6M1.4M
Non Currrent Assets Other2.6M1.8M772.1K(1.0)(1.15)(1.21)
Other Assets578.6K405.5K486.7K1.01.151.09
Cash And Short Term Investments5.9M1.6M667.8K208.5K187.6K178.3K
Common Stock Shares Outstanding200.2M251.2M302.9M362.0M416.3M437.1M
Liabilities And Stockholders Equity10.9M6.0M4.0M2.7M2.4M2.3M
Other Current Assets1.6M1.7M1.5M1.1M1.3M1.3M
Total Liab1.3M1.6M1.5M1.7M1.9M1.7M
Total Current Assets7.4M3.3M2.3M1.3M1.2M1.1M
Common Stock25.0M28.5M29.0M29.8M34.3M36.0M
Short Long Term Debt Total26.8K641.8K700.0111.099.994.91
Property Plant And Equipment Net411.6K353.0K389.7K102.1K117.4K181.9K
Accounts Payable418.1K1.2M1.1M776.2K892.6K760.8K
Net Receivables481.9K1.1M166.3K685.7K788.5K950.7K
Property Plant And Equipment Gross411.6K1.1M1.3M192.3K221.2K280.6K
Accumulated Other Comprehensive Income6.8M8.7M9.3M6.0M6.9M7.3M
Short Term Debt26.8K641.8K700.0111.099.994.91
Intangible Assets484.0K477.6K473.9K447.6K402.8K477.8K
Property Plant Equipment164.7K206.7K411.6K353.0K405.9K426.2K
Current Deferred Revenue(175.4K)(201.0K)(427.7K)(380.1K)(437.1K)(458.9K)
Non Current Liabilities Total22.5K531.9K1.3M1.2M1.5M0.0
Net Tangible Assets5.2M9.6M3.9M2.5M2.8M5.2M
Short Long Term Debt98.3K26.8K641.8K700.0111.00.0
Net Invested Capital10.3M4.4M2.5M1.1M950.7K903.1K
Net Working Capital6.2M1.8M887.6K(321.9K)(289.7K)(275.2K)
Capital Stock25.0M28.5M29.0M29.8M34.3M26.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in ImmuPharma Stock

Balance Sheet is a snapshot of the financial position of ImmuPharma PLC at a specified time, usually calculated after every quarter, six months, or one year. ImmuPharma PLC Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of ImmuPharma PLC and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which ImmuPharma currently owns. An asset can also be divided into two categories, current and non-current.